Sun Pharma ranks second in US dermatology by prescriptions, with key brands including Ilumya for plaque psoriasis and Winlevi for acne. Recent US launches include Leqselvi for severe alopecia areata and Unloxcyt for advanced cutaneous squamous cell carcinoma, strengthening its presence in dermatology and cutaneous oncology.
Sun Pharma to extend MFN pricing to US state Medicaid programmes
By Dhallo News · September 1, 2026 at 10:26 AM IST
Source: Economic Times - Banking & Finance
Original reporting: Economic Times - Banking & FinanceRead original report →
Have feedback on this article?Report error or suggestion